Abbott Laboratories (ETR:ABL)

Abbott Laboratories Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	198,499	168,565	164,260	164,194	213,664	166,895
Market Cap Growth	13.05%	2.62%	0.04%	-23.15%	28.02%	26.68%
Enterprise Value	204,050	172,778	169,892	168,127	219,920	177,060
PE Ratio	16.74	14.80	33.76	28.08	35.72	43.97
Forward PE	24.42	22.39	24.22	26.64	30.05	23.93
PEG Ratio	-	2.61	2.85	5.16	2.38	2.06
PS Ratio	5.41	4.67	4.76	4.37	5.76	5.60
PB Ratio	4.59	4.11	4.94	5.20	6.93	5.92
P/TBV Ratio	3.98	4.15	4.99	5.28	7.03	5.97
P/FCF Ratio	-	30.84	37.73	24.45	28.71	33.88
P/OCF Ratio	-	22.89	26.29	19.91	23.57	24.55
EV/Sales Ratio	5.50	4.79	4.92	4.48	5.93	5.94
EV/EBITDA Ratio	20.07	19.99	20.31	16.80	21.36	23.69
EV/EBIT Ratio	28.54	29.42	30.47	23.36	30.33	38.41
EV/FCF Ratio	35.37	31.61	39.02	25.03	29.55	35.94
Debt / Equity Ratio	0.25	0.26	0.35	0.39	0.48	0.57
Debt / EBITDA Ratio	1.26	1.41	1.51	1.44	1.51	2.16
Debt / FCF Ratio	1.98	2.22	2.90	2.15	2.09	3.28
Asset Turnover	0.52	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	3.15	3.23	3.13	3.73	4.05	3.67
Quick Ratio	1.14	1.05	1.00	1.06	1.28	1.14
Current Ratio	1.82	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	28.32%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	16.08%	16.87%	7.54%	9.33%	9.82%	6.87%
Return on Capital (ROIC)	20.85%	22.29%	10.37%	13.12%	13.36%	8.76%
Return on Capital Employed (ROCE)	10.91%	10.78%	10.95%	13.82%	13.73%	9.11%
Earnings Yield	5.97%	6.75%	2.96%	3.56%	2.80%	2.27%
FCF Yield	2.91%	3.24%	2.65%	4.09%	3.48%	2.95%
Dividend Yield	1.82%	1.95%	1.86%	1.72%	1.28%	1.32%
Payout Ratio	28.42%	28.62%	62.14%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.39%	0.53%	0.56%	1.90%	0.82%	0.08%
Total Shareholder Return	2.21%	2.48%	2.41%	3.62%	2.11%	1.40%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.